Advertisement

Bone marrow mesenchymal stem cells protect lungs from smoke inhalation injury by differentiating into alveolar epithelial cells via Notch signaling

  • Yuan Liang
  • Cunping Yin
  • Xi Lu
  • Hua Jiang
  • Faguang JinEmail author
Article
  • 5 Downloads

Abstract

To examine the protective effect of transplanting bone marrow mesenchymal stem cells (BMSCs) in treating lung injury induced by smoke exposure and to investigate the underlying mechanisms of this protection. SD rats were randomly divided into four groups: normal group, normal + BMSCGFP group, smoke group, and smoke + BMSCGFP group. To detect lung injury, we measured arterial blood gas, the wet-to-dry weight ratio, and levels of interleukin-1β, tumor necrosis factor-α, interleukin-10, and interleukin-13 in bronchoalveolar lavage fluid and lung tissues. We also conducted histopathology examinations. The protein markers of alveolar epithelial cells were measured to determine the BMSC differentiation. The protein levels of Notch1, Jagged-1, and Hes-1 also were detected. In the present study, BMSC transplantation significantly decreased the wet-dry weight ratio of the lung, reduced the production of inflammatory mediators, and alleviated lung injury simply through differentiating into alveolar type II cells and alveolar type I cells. Western blot analysis confirmed that the protein expression of Notch-1, Jagged-1, and Hes-1 increased significantly after systemic BMSC transplantation. No significant difference was observed between the normal group and the normal + BMSCGFP group. Our findings indicate that systemic transplantation of BMSCs alleviated lung injury induced by smoke exposure, which may be associated with BMSCs’ ability to differentiate into alveolar-type cells via the Notch signaling pathway.

Keywords

Alveolar epithelial cells bone marrow mesenchymal stem cells differentiation lung injury Notch signaling smoke inhalation 

Notes

Acknowledgements

This study is supported by funds from military health research projects (14BJ255).

References

  1. Ballardcroft C, Sumpter LR, Broaddus R, Alexander J, Wang D and Zwischenberger JB 2010 Ovine smoke/burn ARDS model: a new ventilator-controlled smoke delivery system. J. Surg. Res. 164 e155–e162CrossRefGoogle Scholar
  2. D’Agostino B, Sullo N, Siniscalco D, De AA and Rossi F 2010 Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opin. Biol. Ther. 10 681CrossRefGoogle Scholar
  3. David P, Dunsford D, Lu J and Moochhala S 2009 Animal models of smoke inhalation induced injuries. Front. Biosci. 14 4618–4630Google Scholar
  4. Gao P, Yang J, Gao X, Xu D, Niu D, Li J and Wen Q 2015 Salvianolic acid B improves bone marrow-derived mesenchymal stem cell differentiation into alveolar epithelial cells type I via Wnt signaling. Mol. Med. Rep. 12 1971CrossRefGoogle Scholar
  5. Gupta N, Su X, Popov B, Lee JW, Serikov V and Matthay MA 2007 Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol. 179 1855CrossRefGoogle Scholar
  6. Huang K, Kang X, Wang X, Wu S, Xiao J, Li Z, Wu X and Zhang W 2015 Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats. Mol. Med. Rep. 11 1685–1692CrossRefGoogle Scholar
  7. Iyer SS, Co C and Rojas M 2009 Mesenchymal stem cells and inflammatory lung diseases. Panminerva Med. 51 5–16PubMedGoogle Scholar
  8. Jones BJ and Mctaggart SJ 2008 Immunosuppression by mesenchymal stromal cells: from culture to clinic. Exp. Hematol. 36 733CrossRefGoogle Scholar
  9. Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M and Marini FC 2009 Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27 2614–2623CrossRefGoogle Scholar
  10. Krasnodembskaya A, Samarani G, Song Y, Zhuo H, Su X, Lee JW, Gupta N, Petrini M and Matthay MA 2012 Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 302 1003–1013CrossRefGoogle Scholar
  11. Lee JW, Fang X, Gupta N, Serikov V and Matthay MA 2009 Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc. Nat. Acad. Sci. USA 106 16357Google Scholar
  12. Li D, Pan X, Zhao J, Chi C, Wu G, Wang Y, Liao S, Wang C, Ma J and Pan J 2016 Bone marrow mesenchymal stem cells suppress acute lung injury induced by lipopolysaccharide through inhibiting the Tlr2, 4/NF-κB pathway in rats with multiple trauma. Shock 45 641CrossRefGoogle Scholar
  13. Ma N, Gai H, Mei J, Ding FB, Bao CR, Nguyen DM and Zhong H 2011 Bone marrow mesenchymal stem cells can differentiate into type II alveolar epithelial cells in vitro. Cell Biol. Int. 35 1261–1266CrossRefGoogle Scholar
  14. Matthay MA, Robriquet L and Fang X 2005 Alveolar epithelium: role in lung fluid balance and acute lung injury. Proc. Am. Thorac. Soc. 2 206–213CrossRefGoogle Scholar
  15. Mei SHJ, Haitsma JJ, Santos CCD, Deng Y, Lai PFH, Slutsky AS, Liles WC and Stewart DJ 2010 Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am. J. Respir. Crit. Care Med. 182 1047–1057CrossRefGoogle Scholar
  16. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH and Brown JM 2009 Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15 42CrossRefGoogle Scholar
  17. Ortiz LA, Gambelli F, Mcbride C, Gaupp D, Baddoo M, Kaminski N and Phinney DG 2003 Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. USA 100 8407–8411CrossRefGoogle Scholar
  18. Phua J, Badia JR, Adhikari NKJ, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A and Jones A 2009 Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am. J. Respir. Crit. Care Med. 179 220–227CrossRefGoogle Scholar
  19. Reagan MR and Kaplan DL 2011 Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems. Stem Cells 29 920–927CrossRefGoogle Scholar
  20. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J and Brigham KL 2005 Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am. J. Respir. Crit. Care Mol. Biol. 33 145CrossRefGoogle Scholar
  21. Skrahin A, Ahmed RK, Ferrara G, Rane L, Poiret T, Isaikina Y, Skrahina A, Zumla A and Maeurer MJ 2014 Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. Lancet Respir. Med. 2 108–122CrossRefGoogle Scholar
  22. Song MJ, Lv Q, Zhang XW, Cao J, Sun SL, Xiao PX, Hou SK, Ding H, Liu ZQ and Dong WL 2016 Dynamic tracking human mesenchymal stem cells tropism following smoke inhalation injury in NOD/SCID Mice. Stem Cells Int. 2016 1–13Google Scholar
  23. Toon MH, Maybauer MO, Greenwood JE, Maybauer DM and Fraser JF 2010 Management of acute smoke inhalation injury. Crit. Care Resuscitation J. Aus. Acad. Crit. Care Med. 12 53–61Google Scholar
  24. Wang L, Tu XH, Zhao P, Song JX and Zou ZD 2012 Protective effect of transplanted bone marrow-derived mesenchymal stem cells on pancreatitis-associated lung injury in rats. Mol. Med. Rep. 6 287CrossRefGoogle Scholar
  25. Wilson JG, Liu KD, Zhuo H, Caballero L, Mcmillan M, Fang X, Cosgrove K, Vojnik R, Calfee CS and Lee JW 2015 Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir. Med. 3 24–32CrossRefGoogle Scholar
  26. Yu JM, Wu X, Gimble JM, Guan X, Freitas MA and Bunnell BA 2011 Age-related changes in mesenchymal stem cells derived from rhesus macaque bone marrow. Aging Cell 10 66–79CrossRefGoogle Scholar
  27. Zhang X, Wang H, Shi Y, Peng W, Zhang S, Zhang W, Xu J, Mei Y and Feng Z 2012 Role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice. Cell Biol. Int. 36 589–594CrossRefGoogle Scholar
  28. Zhao F, Zhang YF, Liu YG, Zhou JJ, Li ZK, Wu CG and Qi HW 2008 Therapeutic Effects of Bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant. Proc. 40 1700–1705CrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 2019

Authors and Affiliations

  • Yuan Liang
    • 1
    • 2
  • Cunping Yin
    • 3
  • Xi Lu
    • 1
  • Hua Jiang
    • 1
  • Faguang Jin
    • 1
    Email author
  1. 1.Department of Respiration, Tangdu HospitalThe Fourth Military Medical UniversityXi’anChina
  2. 2.Department of GeriatricsKunming General HospitalKunmingChina
  3. 3.Department of Vascular SurgeryKunming General HospitalKunmingChina

Personalised recommendations